左心室辅助装置市场战略、顶级参与者、增长机会、2028 年分析和预测

  • Report Code : TIPRE00018950
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 159
Buy Now

Left Ventricular Assist Device Market Share & Size Report 2028

Buy Now

 

[研究报告] 左心室辅助装置市场预计在 2021 年达到 12.7208 亿美元,预计在 2022 年至 2028 年期间的复合年增长率为 5.1%。

左心室辅助装置帮助心脏的左心室将血液泵送到身体的其他部位。它也被称为机械循环支持装置,有助于维持体内正常的血液循环。心血管疾病和心力衰竭患病率的增加以及老年人和肥胖人口的显著增加推动了左心室辅助装置市场的增长。然而,与左心室辅助装置相关的产品召回和并发症的增多阻碍了市场的增长。

该报告提供了对左心室辅助装置市场的见解和深入分析,强调了各种参数,例如市场趋势、技术进步、市场动态以及全球领先市场参与者的竞争格局分析。它还包括 COVID-19 大流行对所有地区市场的影响。由于 COVID-19 大流行,许多卫生当局将重点放在与大流行相关的护理上。他们通过推迟选择性手术、暂停门诊和对参与紧急护理的员工进行分类,避免了由于传播增加和医疗资源紧张而导致的人际接触。此外,许多国家对非临床工作人员进入设施和客人施加了限制。此外,COVID-19 患者中心血管疾病的患病率有所增加,这进一步产生了对左心室辅助装置的需求,从而导致市场增长。最近针对医疗保健专业人员的 COVID-19 指南建议将重点放在紧急护理和分类病例上,以推迟选择性手术和门诊预约,并在适当的时候过渡到虚拟护理。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

左心室辅助装置市场:

左心室辅助装置市场
  • Left Ventricular Assist Device Market
    复合年增长率(2021 - 2028 年)
    5.1%
  • 2021 年市场规模
    12.7 亿美元
  • 2028 年市场规模
    18.1 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • ABIOMED公司
  • 雅培实验室
  • 美敦力公司
  • 利瓦诺瓦股份有限公司
  • 贾维克心脏公司
  • 泰尔茂公司
  • 柏林心脏有限公司
  • BiVACOR公司
  • 伊娃哈特公司

区域概况

Left Ventricular Assist Device Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Left Ventricular Assist Device Market流动类型
  • 脉动和非脉动
Left Ventricular Assist Device Market设计
  • 植入式心室辅助装置和经皮心室辅助装置
Left Ventricular Assist Device Market应用
  • 移植过渡期
  • 目的地治疗
  • 通往复苏之路
  • 候选人资格的桥梁
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

此外,许多左心室辅助装置的制造公司正在通过各种策略应对紧急情况,例如为医护人员制造 PPE、分发药品和其他活动。此外,2020 年 11 月,美敦力和美敦力基金会承诺在全球范围内提供 380 万美元的财政支持,以在食品、运营支持、心理健康支持、PPE 套件等方面为医护人员提供支持。因此,疫情对左心室辅助装置市场产生了短期负面影响。

左心室辅助装置市场根据血流类型、设计、应用和地域进行细分。按地区划分,市场分为北美洲、欧洲、亚太地区、中东和非洲以及南美洲和中美洲。

 

市场洞察

 

 

目标疾病和手术的发病率不断增加

根据世界卫生组织 (WHO) 的数据,心血管疾病 (CVD) 是全球主要死亡原因之一。导致 CVD 和中风患病率上升的几个主要因素是家族史、种族和年龄。吸烟、高血压、高胆固醇、缺乏运动、不健康饮食、过量饮酒以及血脂异常、肥胖和糖尿病等疾病也导致 CVD 患病率上升。根据美国心脏协会的数据,到 2030 年,美国约 41.4% 的成年人将患有高血压(比 2012 年增加 8.4%)。该组织还估计,到 2030 年,全球心血管疾病的成本负担将达到 10,440 亿美元,而 2010 年为 8,630 亿美元。此外,根据世卫组织的估计,到 2030 年,全球因心血管疾病死亡的人数将从 2016 年的约 1,790 万人增加到 2,360 万人。埃默里医疗报告指出,美国在 2022 年记录了约 500 万例充血性衰竭病例,每年诊断出约 55 万例新病例。此外,该国每年报告约 287,000 例因心力衰竭死亡的病例。

根据 Temple Health 的数据,70.9% 的患者在一年内接受了心脏移植,2021 年美国最短的等待名单平均值为 55.2%。全球心脏移植等待名单的增加推动了终末期心力衰竭患者使用左心室辅助装置 (LVAD) 来增加射血分数并防止器官衰竭。因此,心血管疾病和心力衰竭患病率的上升以及心脏移植等待名单的延长推动了 LVAD 的采用,从而推动了左心室辅助装置市场的增长。

 

基于流程的洞察类型

根据血流类型,全球左心室辅助装置市场分为脉动式和非脉动式。2021 年,非脉动式细分市场占据了更大的市场份额,预计在 2022-2028 年期间,该细分市场将实现更高的复合年增长率。

 

基于设计的见解

 

根据设计,左心室辅助装置市场分为植入式心室辅助装置和经皮心室辅助装置。植入式心室辅助装置部分在 2021 年占据了更大的市场份额,预计在预测期内将实现更高的复合年增长率。

 

基于应用的洞察

根据应用,左心室辅助装置市场细分为目的地治疗、移植前桥接、候选前桥接和康复前桥接。目的地治疗部分在 2021 年占据了最大的市场份额,预计在预测期内将实现最高的复合年增长率。

左心室辅助装置市场参与者采用产品发布、产品批准和扩张等有机策略,以扩大其全球业务范围和产品组合并满足不断增长的需求。2020 年 6 月,Abiomed 宣布美国食品药品监督管理局 (FDA) 批准其试验设备豁免申请,以启动 Impella ECP 心脏泵的早期可行性研究和首次人体试验。

 

基于地理位置的洞察

根据地域划分,左心室辅助装置市场分为北美(美国、加拿大和墨西哥)、欧洲(法国、德国、英国、西班牙、意大利和欧洲其他地区)、亚太地区(中国、印度、日本、澳大利亚、韩国和亚太地区其他地区)、中东和非洲(沙特阿拉伯、阿联酋、南非和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。

 

左心室辅助装置市场报告范围

报告属性细节
2021 年市场规模12.7亿美元
2028 年市场规模18.1亿美元
全球复合年增长率(2021 - 2028)5.1%
历史数据2019-2020
预测期2022-2028
涵盖的领域按流程类型
  • 脉动和非脉动
通过设计
  • 植入式心室辅助装置和经皮心室辅助装置
按应用
  • 移植过渡期
  • 目的地治疗
  • 通往复苏之路
  • 候选人资格的桥梁
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • ABIOMED公司
  • 雅培实验室
  • 美敦力公司
  • 利瓦诺瓦股份有限公司
  • 贾维克心脏公司
  • 泰尔茂公司
  • 柏林心脏有限公司
  • BiVACOR公司
  • 伊娃哈特公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

基于公司的见解

ABIOMED Inc、Abbott Laboratories、Medtronic Plc、LivaNova Plc、Jarvik Heart Inc、Terumo Corp、Berlin Heart GmbH、BiVACOR Inc、Evaheart Inc 和 BioVentrix Inc. 是左心室辅助装置市场的领先公司。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the left ventricular assist device market across the globe?

Increasing incidence of target diseases and procedures and growing geriatric population are the most significant factors responsible for the overall market growth.

Which type of flow segment led the left ventricular assist device market?

Based on type of flow segment, the non-pulsatile segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

Which application segment held the largest market share in the left ventricular assist device market?

Based on the application, destination therapy segment took the forefront leaders in the worldwide market by accounting largest share in 2021.

Which design segment held the largest market share in the left ventricular assist device market?

Implantable ventricular assist device segment dominated the global left ventricular assist device market and accounted for the largest market share during the forecast period of 2022-2028.

What is meant by the left ventricular assist device market?

Left ventricular assist device is a mechanical pump implanted in heart failure. This device helps the left ventricle of the heart in pumping blood to the rest of the body. It is also known as a mechanical circulatory support device that helps in maintaining proper blood circulation within the body.

What is the regional market scenario of the left ventricular assist device market?

Global left ventricular assist device market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for left ventricular assist device market. According to the Centers for Disease Control and Prevention (CDC), ~6.2 million adults in the US suffer from heart failure, and it was the cause of death of ~697,000 people in 2018. According to the data provided by the American Heart Association Inc., ~1 million new heart failure cases are registered annually in the US, and more than 8 million people are estimated to suffer from heart failure by 2030. According to the Health Research Funding Organization, ~555,000 people were diagnosed with the beginning stages of heart failure in the US in 2021, and ~300,000 patients in the US qualify for a left ventricular assist device (LVAD) because of their terminal heart conditions. Cardiovascular diseases (CVDs) generally lead to heart failure or terminal heart disease, which bolsters the demand for LVADs that ensure proper heart functioning. Such aforementioned facto acts as a standalone factor responsible for the overall market growth of left ventricular assist device in the US during the forecast period of 2022-2028.

Who are the key players in the left ventricular assist device market?

ABIOMED Inc, Abbott Laboratories, Medtronic Plc, LivaNova Plc, Jarvik Heart Inc, Terumo Corp, Berlin Heart GmbH, BiVACOR Inc, Evaheart Inc, and BioVentrix Inc, and among others are among the leading companies operating in the left ventricular assist device market.

The List of Companies - Left Ventricular Assist Device Market

  1. ABIOMED Inc
  2. Abbott Laboratories
  3. Medtronic Plc
  4. LivaNova Plc
  5. Jarvik Heart Inc
  6. Terumo Corp
  7. Berlin Heart GmbH
  8. BiVACOR Inc
  9. Evaheart Inc
  10. BioVentrix Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..